Literature DB >> 28780066

Risk factors for measles among infants in Tianjin, China.

Y Zhang1, A L Wagner2, X Wang1, B F Carlson3, Y Ding1, J P Montgomery3, B W Gillespie4, M L Boulton5.   

Abstract

OBJECTIVES: Infants aged <8 months are ineligible for measles vaccination in China but represent a disproportionate number of cases. We examined the risk factors for measles among infants in Tianjin, China. STUDY
DESIGN: Case-control study.
METHODS: Cases were enrolled from a surveillance system, and IgG-negative controls were sampled from registries at immunization clinics. A logistic regression model assessed for risk factors.
RESULTS: Among 82 cases and 485 controls, exposure to a municipal hospital (OR [odds ratio]: 5.21; 95% confidence interval [CI]: 1.19-22.82) or a specialty hospital (OR: 13.22; 95% CI: 6.13-28.51) was associated with the disease, whereas visiting a township or district hospitals was not associated with increased odds of measles.
CONCLUSIONS: Hospitals were an important focal point of measles transmission for infants. Hospitals, particularly higher-level municipal and specialty hospitals, should enforce infection control programs to separate infants with highly communicable diseases to prevent transmission.
Copyright © 2017 The Royal Society for Public Health. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  China; Infants; Measles

Mesh:

Year:  2017        PMID: 28780066      PMCID: PMC5612882          DOI: 10.1016/j.puhe.2017.07.001

Source DB:  PubMed          Journal:  Public Health        ISSN: 0033-3506            Impact factor:   2.427


  4 in total

1.  The epidemiology of measles in Tianjin, China, 2005-2014.

Authors:  Xiexiu Wang; Matthew L Boulton; JoLynn P Montgomery; Bradley Carlson; Ying Zhang; Brenda Gillespie; Abram L Wagner; Yaxing Ding; Xiaoyan Luo; Tian Hong
Journal:  Vaccine       Date:  2015-10-17       Impact factor: 3.641

2.  A population profile of measles susceptibility in Tianjin, China.

Authors:  Matthew L Boulton; Xiexiu Wang; Ying Zhang; JoLynn P Montgomery; Abram L Wagner; Bradley F Carlson; Yaxing Ding; Xiaoyan Li; Brenda Gillespie; Xu Su
Journal:  Vaccine       Date:  2016-05-03       Impact factor: 3.641

3.  Monitoring progress towards the elimination of measles in China: an analysis of measles surveillance data.

Authors:  Chao Ma; Lixin Hao; Yan Zhang; Qiru Su; Lance Rodewald; Zhijie An; Wenzhou Yu; Jing Ma; Ning Wen; Huiling Wang; Xiaofeng Liang; Huaqing Wang; Weizhong Yang; Li Li; Huiming Luo
Journal:  Bull World Health Organ       Date:  2014-02-05       Impact factor: 9.408

4.  Risk factors for measles infection in 0-7 month old children in China after the 2010 nationwide measles campaign: A multi-site case-control study, 2012-2013.

Authors:  Chao Ma; Christopher J Gregory; Lixin Hao; Kathleen A Wannemuehler; Qiru Su; Zhijie An; Linda Quick; Lance Rodewald; Fubao Ma; Rui Yan; Lizhi Song; Yanyang Zhang; Yi Kong; Xiaoshu Zhang; Huaqing Wang; Li Li; Lisa Cairns; Ning Wang; Huiming Luo
Journal:  Vaccine       Date:  2016-03-21       Impact factor: 3.641

  4 in total
  4 in total

1.  Measles vaccination of young infants in China: A cost-effectiveness analysis.

Authors:  Cara Bess Janusz; Abram L Wagner; Nina B Masters; Yaxing Ding; Ying Zhang; David W Hutton; Matthew L Boulton
Journal:  Vaccine       Date:  2020-05-22       Impact factor: 3.641

2.  Assessing measles vaccine failure in Tianjin, China.

Authors:  Nina B Masters; Abram L Wagner; Yaxing Ding; Ying Zhang; Matthew L Boulton
Journal:  Vaccine       Date:  2019-05-08       Impact factor: 3.641

3.  Measles Antibodies in Mother-Infant Dyads in Tianjin, China.

Authors:  Matthew L Boulton; Xiexiu Wang; Abram L Wagner; Ying Zhang; Bradley F Carlson; Brenda W Gillespie; Yaxing Ding
Journal:  J Infect Dis       Date:  2017-11-27       Impact factor: 5.226

4.  Dried blood spots: An evaluation of utility in the field.

Authors:  Xu Su; Bradley F Carlson; Xiexiu Wang; Xiaoyan Li; Ying Zhang; JoLynn P Montgomery; Yaxing Ding; Abram L Wagner; Brenda Gillespie; Matthew L Boulton
Journal:  J Infect Public Health       Date:  2017-09-28       Impact factor: 3.718

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.